Are biohacking peptides actually worth it?

No—if you are a healthy 24-year-old, 6'1", 200 lb male interested in broad biohacking optimization, you generally should not take peptides. The strongest reason is that for someone young and healthy, the peptide market’s biggest categories outside true medical treatment—GH secretagogues, recovery peptides like BPC-157/TB-500, longevity/nootropic peptides, and most sexual/cosmetic compounds—have weak or population-mismatched human evidence, while real risks include endocrine disruption, glucose intolerance, edema, blood-pressure effects, fertility-axis interference, contamination, dosing error, and unknown long-term safety.[1]fda.gov +3

The main exception is narrow, diagnosis-driven, physician-supervised use of legitimate approved peptide drugs—most notably GLP-1/incretin therapy if you truly meet obesity/overweight treatment criteria, or specialist-managed endocrine/fertility therapy for an actual disorder—not “optimization” stacks or clinic-marketed hormone support.[2][3][4]dailymed.nlm.nih.gov +3

The biggest caveat is regulatory and quality: compounded products are not FDA-approved, and gray-market “research peptides” are explicitly not lawful human-use drugs, with FDA warning about dosing mistakes, fraudulent labels, wrong salt forms, warm shipping, and serious adverse events even in compounded GLP-1s.[5][4]fda.gov +1

Practical conclusion: avoid peptides entirely for broad optimization; only consider a peptide-related therapy if you have a real diagnosed condition, qualify for an approved treatment, and are willing to do it through a conventional physician-supervised pathway rather than compounding-by-convenience or self-experimentation.[4][5]fda.gov +3